Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
June 7, 2017
Academia and Government
June 6, 2017
Academia and Government
June 6, 2017
Academia and Government
June 2, 2017
Academia and Government
June 1, 2017
Life Sciences and Healthcare
May 31, 2017
Academia and Government
May 31, 2017
Intellectual Property
May 29, 2017
Academia and Government
May 23, 2017